Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients
Conditions: Malnutrition, Child; Malnutrition Intervention: Drug: SMOFlipid® (lipid injectable emulsion) Sponsor: Fresenius Kabi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials